Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain and Central Nervous System Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00004015
What this trial is testing

Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 36
Testing effectiveness (Phase 2)Study completedNCT00006268
What this trial is testing

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Not applicableStudy completedNCT07247526
What this trial is testing

Effect of Foot Bath on Anxiety and Physiological Parameters

Who this might be right for
Pituitary AdenomaSurgery
Trakya University 100
Not applicableStudy completedNCT06168825
What this trial is testing

Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention

Who this might be right for
CancerBreast CancerBrain Cancer+13 more
Inova Health Care Services 40
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Study completedNCT00003616
What this trial is testing

Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT04796935
What this trial is testing

Test Performance of Needle Placements for Neuraxial Procedures Using Tactile Imaging vs Control

Who this might be right for
Central Nervous System InfectionsPseudotumor CerebriNeurological Disorder+4 more
IntuiTap Medical, Inc 95
Testing effectiveness (Phase 2)Study completedNCT00381797
What this trial is testing

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Who this might be right for
Childhood Cerebral Anaplastic AstrocytomaChildhood OligodendrogliomaChildhood Spinal Cord Neoplasm+3 more
National Cancer Institute (NCI) 97
Testing effectiveness (Phase 2)Ended earlyNCT00972335
What this trial is testing

Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma

Who this might be right for
Intracranial Meningioma
SCRI Development Innovations, LLC 18
Not applicableStudy completedNCT00005459
What this trial is testing

Risk of Coronary Heart Disease in Women With Polycystic Ovary Syndrome

Who this might be right for
AtherosclerosisCardiovascular DiseasesHeart Diseases+3 more
National Heart, Lung, and Blood Institute (NHLBI)
Early research (Phase 1)Study completedNCT01222780
What this trial is testing

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+3 more
Acrotech Biopharma Inc. 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07343479
What this trial is testing

Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)EGFR Gene MutationsBrain Metastasis
Zhejiang Cancer Hospital 45
Not applicableStudy completedNCT00285324
What this trial is testing

Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis

Who this might be right for
Glioma Tumor RecurrenceRadiation NecrosisPrimary Brain Tumor
National Institute of Neurological Disorders and Stroke (NINDS) 29
Early research (Phase 1)WithdrawnNCT01130623
What this trial is testing

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02303678
What this trial is testing

D2C7 for Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaBrain Tumor, Recurrent
Darell Bigner 81
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableLooking for participantsNCT05370079
What this trial is testing

Control Cohort CTRL COH

Who this might be right for
Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis
Hospices Civils de Lyon 350
Post-approval studies (Phase 4)UnknownNCT04399343
What this trial is testing

Dexmedetomidine for Prevention of Postoperative Delirium After Intracranial Operation for Brain Tumor

Who this might be right for
Central Nervous System Diseases
Capital Medical University 700
Testing effectiveness (Phase 2)Study completedNCT00058123
What this trial is testing

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Testing effectiveness (Phase 2)Ended earlyNCT00074334
What this trial is testing

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 3
Next Page